These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25040887)

  • 1. Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A1 adenosine receptor.
    Guo D; Venhorst SN; Massink A; van Veldhoven JP; Vauquelin G; IJzerman AP; Heitman LH
    Br J Pharmacol; 2014 Dec; 171(23):5295-312. PubMed ID: 25040887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2.
    Doornbos MLJ; Vermond SC; Lavreysen H; Tresadern G; IJzerman AP; Heitman LH
    Biochem Pharmacol; 2018 Sep; 155():356-365. PubMed ID: 30028996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid ortho/allosteric ligands for the adenosine A(1) receptor.
    Narlawar R; Lane JR; Doddareddy M; Lin J; Brussee J; Ijzerman AP
    J Med Chem; 2010 Apr; 53(8):3028-37. PubMed ID: 20345101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
    Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
    Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scintillation proximity assay (SPA) as a new approach to determine a ligand's kinetic profile. A case in point for the adenosine A1 receptor.
    Xia L; de Vries H; IJzerman AP; Heitman LH
    Purinergic Signal; 2016 Mar; 12(1):115-26. PubMed ID: 26647040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probe dependence of allosteric enhancers on the binding affinity of adenosine A
    Cooper SL; Soave M; Jörg M; Scammells PJ; Woolard J; Hill SJ
    Br J Pharmacol; 2019 Apr; 176(7):864-878. PubMed ID: 30644086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-state model for the kinetics of competitive radioligand binding.
    Guo D; Peletier LA; Bridge L; Keur W; de Vries H; Zweemer A; Heitman LH; IJzerman AP
    Br J Pharmacol; 2018 May; 175(10):1719-1730. PubMed ID: 29486053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization.
    Hill SJ; May LT; Kellam B; Woolard J
    Br J Pharmacol; 2014 Mar; 171(5):1102-13. PubMed ID: 24024783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Loop 2 of the Adenosine A1 Receptor Has a Key Role in Orthosteric Ligand Affinity and Agonist Efficacy.
    Nguyen AT; Baltos JA; Thomas T; Nguyen TD; Muñoz LL; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
    Mol Pharmacol; 2016 Dec; 90(6):703-714. PubMed ID: 27683014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric Antagonism of the A
    Gao ZG; Toti KS; Campbell R; Suresh RR; Yang H; Jacobson KA
    Cells; 2020 May; 9(5):. PubMed ID: 32408534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An allosteric modulator of the adenosine A
    Fu K; Chen W; Meng M; Zhao H; Yuan H; Wang Y; Ren Y; Yun Y; Guo D
    Eur J Pharmacol; 2023 Jul; 951():175777. PubMed ID: 37182594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor.
    Avlani VA; Langmead CJ; Guida E; Wood MD; Tehan BG; Herdon HJ; Watson JM; Sexton PM; Christopoulos A
    Mol Pharmacol; 2010 Jul; 78(1):94-104. PubMed ID: 20413650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonists.
    Aurelio L; Valant C; Figler H; Flynn BL; Linden J; Sexton PM; Christopoulos A; Scammells PJ
    Bioorg Med Chem; 2009 Oct; 17(20):7353-61. PubMed ID: 19751980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand.
    Valant C; Gregory KJ; Hall NE; Scammells PJ; Lew MJ; Sexton PM; Christopoulos A
    J Biol Chem; 2008 Oct; 283(43):29312-21. PubMed ID: 18723515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist.
    Valant C; May LT; Aurelio L; Chuo CH; White PJ; Baltos JA; Sexton PM; Scammells PJ; Christopoulos A
    Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4614-9. PubMed ID: 24619092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators.
    Jakubík J; Randáková A; El-Fakahany EE; Doležal V
    PLoS One; 2019; 14(3):e0214255. PubMed ID: 30917186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of novel 2-amino-3-benzoylthiophene derivatives as biased allosteric agonists and modulators of the adenosine A(1) receptor.
    Valant C; Aurelio L; Devine SM; Ashton TD; White JM; Sexton PM; Christopoulos A; Scammells PJ
    J Med Chem; 2012 Mar; 55(5):2367-75. PubMed ID: 22315963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract Guanine nucleotide effects on agonist binding.
    Figler H; Olsson RA; Linden J
    Mol Pharmacol; 2003 Dec; 64(6):1557-64. PubMed ID: 14645687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.